Concepedia

David Altarac

DA

3

Publications

781

Citations

3

H-Index

1992

Active since

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Mount Sinai Beth Israel

David Altarac is an author at Icahn School of Medicine at Mount Sinai specializing in antibiotics, infection control, and medicine.

Top concepts

MedicineAntibioticsInfection ControlClinical MicrobiologyAntimicrobial ResistanceHealthMicrobiologyDrug ResistanceBacterial ResistanceAntimicrobial Stewardship

Publications per year

1992–2023

3

Publications

3

Nosocomial Outbreak Due to Enterococcus faecium Highly Resistant to Vancomycin, Penicillin, and Gentamicin

S Handwerger, B. Raucher, David Altarac et al. · Clinical Infectious Diseases · 1993 · 441 citations

Peritoneal Dialysis Fluid, Pathogenic Microbiology, Antibiotic Resistance +18

Efficacy and safety of sulbactam–durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii–calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)

Keith S. Kaye, Andrew F. Shorr, Richard G. Wunderink et al. · The Lancet Infectious Diseases · 2023 · 238 citations

Antimicrobial Susceptibility, Antimicrobial Stewardship, Antibiotics +12

Concomitant High-Level Vancomycin and Penicillin Resistance in Clinical Isolates of Enterococci

S Handwerger, David C. Perlman, David Altarac et al. · Clinical Infectious Diseases · 1992 · 102 citations

Vancomycin Induction, Antimicrobial Susceptibility, Health Sciences +15

Rows per page

1–3 of 3